Search
for

    Sort by

    Research 781–810 of 1000+

    1. Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia Global Journal of Reproductive Medicine · 2023
    2. 5α-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression 2020
    3. MON-LB044 Bilateral Ovarian Hyperthecosis: A Benign and Unusual Cause of Postmenopausal Hirsutism Journal of the Endocrine Society · 2019
    4. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    5. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    6. Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia European Urology · 2000 · 184 citations
    7. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia Translational Andrology and Urology · 2019 · 110 citations
    8. Trichodiscoma. A Benign Tumor Related to Haarschibe (Hair Disk) Journal of Investigative Dermatology · 1974 · 87 citations
    9. The therapeutic use of topical contact sensitizers in benign dermatoses 2001 · 60 citations
    10. Immunohistochemical demonstration of keratins 8 and 14 in benign tumours of the skin appendage Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1991 · 38 citations
    11. Basement membrane Laminin and Type IV Collagen in Various Benign and Malignant Adnexal Tumors of the Skin: An Immunohistochemical Study Journal of Investigative Dermatology · 1984 · 28 citations
    12. The therapeutic use of topical contact sensitizers in benign dermatoses 2008 · 23 citations
    13. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle. PubMed · 2010 · 17 citations
    14. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    15. A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia Drug safety · 1998 · 12 citations
    16. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia European urology. Supplement · 2009 · 10 citations
    17. Isolated episcleral plasmacytoma mimicking episcleritis in a patient with benign monoclonal gammopathy British Journal of Ophthalmology · 2001 · 3 citations
    18. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I Mayo Clinic Proceedings · 2006 · 2 citations
    19. Management of Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia During and After COVID-19 Société internationale d'urologie journal · 2021 · 1 citations
    20. Effect of metabolic syndrome on treatment outcome of lower urinary tract symptoms in males due to benign prostatic hyperplasia Panacea Journal of Medical Sciences · 2020 · 1 citations
    21. 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction Cochrane library · 2015 · 1 citations
    22. Subtle Trichilemmal Carcinoma of Neck Initially Misdiagnosed as Benign Cyst and Ultimately Treated with Mohs Micrographic Surgery Skin · 2023
    23. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    24. Eficacia de la combinación de doxazosina y finasterida en la hipertrofia benigna de próstata Actualidad en farmacología y terapéutica · 2004
    25. Ocular Side Effects of Eyelash Extension Use Among Female Students of the University of Benin, Benin City, Edo State, Nigeria Cureus · 2024 · 3 citations
    26. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    27. Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia Journal of pharmaceutical sciences · 2013 · 13 citations
    28. Pathogenetic justification of the use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Experimental and Сlinical Urology · 2022 · 4 citations
    29. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    30. Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours Stem cells international · 2019 · 3 citations